Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Empliciti
Empliciti
2 newer multiple myeloma drugs fall short in bid for wider market
BioPharma Dive
Tue, 03/10/20 - 11:58 am
Multiple Myeloma
clinical trials
Bristol-Myers Squibb
Takeda
Ninlaro
Empliciti
Revlimid
Bristol Myers flunks frontline multiple myeloma trial, turning attention to cell therapy
Endpoints
Mon, 03/9/20 - 10:52 am
Bristol-Myers Squibb
Celgene
M&A
clinical trials
Multiple Myeloma
Empliciti
AbbVie
Revlimid
Bristol-Myers, AbbVie's multiple myeloma drug wins second EU nod as part of triple regimen
Endpoints
Wed, 08/28/19 - 12:38 pm
Bristol-Myers Squibb
AbbVie
Empliciti
Celgene
Europe
relapsed or refractory multiple myeloma
Bristol-Myers Squibb snags quick Empliciti combo nod in multiple myeloma
Fierce Pharma
Thu, 11/8/18 - 09:41 am
Bristol-Myers Squibb
AbbVie
Empliciti
FDA
Multiple Myeloma
Celgene
Pomalyst
Bristol-Myers (BMY) sBLA for Empliciti Gets Priority Review
Yahoo/Zacks.com
Fri, 08/24/18 - 11:08 am
Bristol-Myers Squibb
Empliciti
Celgene
Pomalyst
Multiple Myeloma
Bristol-Myers, AbbVie eye new use for myeloma drug Empliciti after phase 2 combo win
Fierce Pharma
Mon, 06/18/18 - 09:47 pm
Bristol-Myers Squibb
AbbVie
Empliciti
Multiple Myeloma
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Wed, 05/4/16 - 09:48 am
Amgen
Kyprolis
JNJ
Bristol-Myers Squibb
Multiple Myeloma
Darzalex
Empliciti
AbbVie
Takeda
Ninlaro
New myeloma meds work better than the old, but they're far too expensive: Report
Fierce Biotech
Tue, 04/12/16 - 03:39 pm
Multiple Myeloma
Bristol-Myers Squibb
Amgen
Takeda
Empliciti
Kyprolis
Ninlaro
Celgene
Revlimid
Bristol Myers’s Empliciti Receives FDA Approval
Yahoo/Market Realist
Tue, 12/15/15 - 09:47 am
Bristol-Myers Squibb
Empliciti
FDA
Multiple Myeloma
Can Bristol-Myers Squibb And AbbVie's Empliciti Become a Top Seller?
Motley Fool
Tue, 12/1/15 - 01:18 pm
AbbVie
Bristol-Myers Squibb
Empliciti
Multiple Myeloma
Will Bristol-Myers (BMY) Stock Be Helped by Myeloma Gaining FDA Priority Review Approval?
TheStreet.com
Tue, 09/1/15 - 06:46 pm
Bristol-Myers Squibb
priority review
FDA
Multiple Myeloma
Empliciti